In this protocol, the investigators are examining the use of a novel pathogen testing technology and method of identification of antibiotic susceptibility against the conventional C \& S testing for patients with both complicated and uncomplicated UTIs. The investigators will examine the two modes in terms of objective patient related outcomes, i.e. 1) diagnostic accuracy and degree of detail of final analysis; 2) time to resolution of symptoms; 3) quality of life as defined by particularly symptomology and "bothersomeness" of the symptoms; and 4) overall cost.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
50
Treatment based on the results of the FH C \& S testing - Odd Numbers on randomization table
To quantify differences in the relative abundance and presence of microbial lineages as determined by culture and sequencing technologies.
comparison of culture and sensitivity results to the molecular results
Time frame: 1 year
Time (as measured in hours) to preliminary and final identification of organism(s) and antibiotic sensitivity(s) results
time from collection of sample to diagnostic result delivery
Time frame: 1 year
Time from participant reported start of UTI symptoms to resolution.
collect time of reported UTI from Subject
Time frame: 1 year
Participant Quality of Life as measured by a UTI specific severity and bothersome of symptoms survey taken at baseline (at clinic visit) and at set time points post urine testing
collect data from Subject as outlined in the Quality of Life Assessment
Time frame: 1 year
Overall cost
collect data on the overall cost of Subject treatment
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.